Staphylococcus aureus (S aureus) is a type of bacterium. Like other kinds of bacteria, S aureus frequently lives on the skin and in the nose without causing health problems. Staphylococcus aureus becomes a problem when it is a source of infection in the skin, lungs, or blood. These bacteria can be spread from one person to another through casual contact or through sharing contaminated objects. Methicillin-resistant Staphylococcus aureus (MRSA ) bacteria are resistant to commonly used antibiotics, the medicines used to treat bacterial infections. Because of this, MRSA infections are more difficult to treat than ordinary S aureus infections. MRSA that is acquired in a hospital is called hospital-associated MRSA (HA-MRSA ). MRSA infections are now becoming more common in healthy, nonhospitalized persons. These infections can occur among young people with cuts or wounds who have close contact with each other, such as members of sports teams. This type of MRSA is called community-acquired MRSA (CA-MRSA ). This Patient Page is based on one originally published in the October 17, 2007, issue of JAMA.
Leading causes of antibiotic resistance include
Bacterial mutation—bacteria that survive treatment with one antibiotic may develop resistance to the effects of that drug and similar medicines.
Unnecessary antibiotic use—for decades, antibiotics have been prescribed for colds, flu, and other viral infections that do not require or respond to antibiotics.
Antibiotics in food—antibiotics are commonly given to cattle, pigs, and chickens.
Risk factors for HA-MRSA include
Current or recent hospitalization
Residence in a long-term care facility
Invasive procedures such as urinary catheters, intra-arterial lines, or central venous lines
Recent or long-term antibiotic use
Family members or close contacts who are health care workers
Chronic renal dialysis
Risk factors for CA-MRSA include
Participation in contact sports
Sharing towels or athletic equipment
Having a weakened immune system, such as in persons with HIV/AIDS
Living in crowded or unsanitary conditions, such as prisons
Both HA-MRSA and CA-MRSA still respond to certain medications. Doctors usually treat suspected and confirmed infections with vancomycin, but resistance to vancomycin can also occur. Few other drugs are available. Current research is directed toward development of new antibiotics.
To prevent the spread of MRSA:
Ask hospital staff to wash their hands before touching you.
Wash your own hands frequently and avoid sharing personal items like razors or towels.
Follow hospitals' isolation procedures for gowns, gloves, and masks.
Wipe down shared equipment at gyms before and after using them.
Athletes should participate in sports only if any open wounds can be kept covered during participation.
Centers for Disease Control and Prevention www.cdc.gov/mrsa
Mayo Clinic Health Information www.mayoclinic.com/health/mrsa/DS00735
American Academy of Pediatrics Healthy Children www.healthychildren.org
To find this and previous JAMA Patient Pages, go to the Patient Page Index on JAMA's Web site at www.jama.com. Many are available in English and Spanish.
Sources: Centers for Disease Control and Prevention, Mayo Clinic
Topic: INFECTIOUS DISEASES
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.